2nd Quarter - Report

AMERICAN SOCIETY OF CONSULTANT PHARMACISTS for AMERICAN SOCIETY OF CONSULTANT PHARMACISTS

Firm
Client
Income
—
Expenses
$40,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Pharmacy Lock-in (s.1913, S.524), Pharmacy provider status (H.R. 592/S.314),

LobbyistCovered position, as disclosed
PETER RANKIN Director of Policy and Advocacy

Contacted: Drug Enforcement Administration (DEA); Centers For Medicare and Medicaid Services (CMS); HOUSE OF REPRESENTATIVES; SENATE; Food & Drug Administration (FDA)

Bills named: S. 524 (114th), H.R. 592 (114th), S. 1913 (114th), S. 314 (114th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.